Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells.

@article{Wen2015EvodiamineAN,
  title={Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells.},
  author={Zhenzhen Wen and Shujiong Feng and Lijuan Wei and Zhimin Wang and DeFei Hong and Qiang Wang},
  journal={International journal of molecular medicine},
  year={2015},
  volume={36 6},
  pages={
          1657-63
        }
}
Gastric cancer stem cells (GCSCs) have an important role in metastasis and recurrence of gastric cancer, and novel treatment strategies that target GCSCs are urgently required. Although evodiamine (Evo), a derivative of the traditional herbal medicine Evodia rutaecarpa, has been reported to have various biological effects, its effect on GCSCs remains unknown. In order to determine the effect of Evo on apoptosis of GCSCs, an MTS assay, flow cytometry and western blot analysis were performed. The… 

Figures and Tables from this paper

Induction of Apoptosis and Effect on the FAK/AKT/mTOR Signal Pathway by Evodiamine in Gastric Cancer Cells

The cytotoxic activity of evodiamine is confirmed against AGS and MKN45 cells by a WST assay, cell morphological change, and clonogenic assay, and the expressions of apoptosis-related molecules were confirmed by Western blot.

Evodiamine inhibits stemness and metastasis by altering the SOX9–β‐catenin axis in non‐small‐cell lung cancer

Investigation of EVO's role in inhibiting cell proliferation and migration in A549 and NCI‐H522 lung cancer cells revealed that EVO treatment showed downregulation of SOX9, an upstream component of β‐catenin.

Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial–Mesenchymal Transition of Thyroid Carcinoma Cells

Evodiamine was cytotoxic towards thyroid carcinoma cells, and repression of AKT reinforced evodiumine-induced cytotoxicity, and evodiamines ameliorated proliferation, migration and epithelial–mesenchymal transition, and synergized with chemotherapeutic agents.

Evodiamine Inhibits Gastric Cancer Cell Proliferation via PTEN-Mediated EGF/PI3K Signaling Pathway

Investigation of the pharmacological effects and potential molecular mechanisms of evodiamine in treating gastric cancer revealed that it might serve as a potential candidate for the treatment or prevention of GC.

Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-κB Signaling Pathway

Evodiamine is the active compound of EF to inhibit proliferation and migration of prostate cancer through PI3K/AKT/NF-κB signaling pathway, indicating that evodiamines may serve as a potential lead drug for prostate cancer treatment.

Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers.

This review summarizes the ongoing research on the mechanisms behind the antitumor potential of evodiamine, which proposes an exciting future for such interests in cancer biology.

Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway

Evidence is provided that evodiamine dose- and time-dependently inhibits both Mus musculus and Homo sapiens hepatocellular carcinoma (HCC) cells, as well as Hepa1-6 and HepG2 cell proliferation, and activated WWOX to exert an anti-HCC activity.

Pancreatic cancer stem cells mediate drug resistance against evodiamine by activation of HIF-1α-Notch-Hes1/5 pathway

Investigating the contribution of pancreatic CSCs in Evodiamine (Evo) resistance revealed that the key signaling proteins involved in HIF-1α-Notch-Hes1/5 pathway were significantly up regulated in Evo-resistant pancreatic cancer cells.

A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells

Based on observations, evodiamine can reverse the TAF-induced EMT-like phenotype in colon epithelial cells, which may be associated with its mediation of phosphorylated Smad2 and Smad3 expression.

Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development

It is apparent that selective targeting of CSCs with plants, plant preparations, and plant-derived bioactive compounds, termed phytochemicals, may be a promising strategy for the treatment of relapsed cancers.

References

SHOWING 1-10 OF 33 REFERENCES

Growth inhibition and induction of apoptosis in SGC‑7901 human gastric cancer cells by evodiamine.

  • Li YangXin Liu Hai Huang
  • Biology, Chemistry
    Molecular medicine reports
  • 2014
The results suggest that evodiamine is able to inhibit the proliferation of S GC-7901 cells by inhibiting the cell cycle at G2/M phase and inducing apoptosis in SGC-79 01 cells by activating caspase-3, -8 and -9, and altering the expression of casp enzyme, Bax and Bcl-2.

Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy.

It is found that evodiamine significantly inhibited the proliferation of SGC-7901 cells and induced G2/M phase cell cycle arrest, and may represent a candidate for in-vivo studies of monotherapies or combined antitumor therapies.

Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein

The data indicate that EVO, a natural product, may be useful applied alone or in combination with DOX for the treatment of resistant breast cancer.

Activation of JNK Contributes to Evodiamine-Induced Apoptosis and G2/M Arrest in Human Colorectal Carcinoma Cells: A Structure-Activity Study of Evodiamine

Data of the structure-activity analysis showed that EVO-related chemicals containing an alkyl group at position 14 were able to induce apoptosis, G2/M arrest associated with increased DNA ladder formation, cleavage of caspase-3 and PARP, and elevated cycB1 and cdc25c protein expressions in COLO205 and HT-29 cells.

Gastric cancer stem cells: therapeutic targets

New therapeutic tools based on specific properties and functions of CSCs, including activation of self-renewal signaling pathways, differences in gene expression profiles, and increased activity of telomerase or chemoresistance mechanisms, are developing in parallel with advances in nanotechnology and bioengineering.

Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment

It is suggested that Wnt signaling might have a critical role in the self-renewal of gastric CSCs, and salinomycin targeting WNT signaling may have important clinical applications in gastric cancer therapy.

Downregulation of GSK3β by miR-544a to maintain self-renewal ability of lung caner stem cells

In order to study the influence and mechanism of miR-544a on the self-renewal ability of lung cancer stem cells, TargetScan was used to predict the target gene of miR-544a. A luciferase reporter

Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

The results support the notion that the Oct4/Nanog signaling controls epithelial-mesenchymal transdifferentiation, regulates tumor-initiating ability, and promotes metastasis of LAC.

Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44

The existence of gastric CSCs is identified from a panel of human gastric cancer cell lines using cell surface marker CD44 and these cells showed the stem cell properties of self‐renewal and the ability to form differentiated progeny and gave rise to CD44(−) cells.